Hans‐Michael Steffen

4.6k total citations · 1 hit paper
139 papers, 3.2k citations indexed

About

Hans‐Michael Steffen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Hans‐Michael Steffen has authored 139 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 27 papers in Hepatology and 25 papers in Surgery. Recurrent topics in Hans‐Michael Steffen's work include Liver Disease Diagnosis and Treatment (34 papers), Liver Disease and Transplantation (14 papers) and Diet, Metabolism, and Disease (9 papers). Hans‐Michael Steffen is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Liver Disease and Transplantation (14 papers) and Diet, Metabolism, and Disease (9 papers). Hans‐Michael Steffen collaborates with scholars based in Germany, United States and Switzerland. Hans‐Michael Steffen's co-authors include Münevver Demir, Sonja Lang, W. Hein, A. Supersaxo, Tobias Goeser, Philipp Kasper, Anna Martin, Fabian Kütting, H. Van der Loos and Jochem Alsenz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Hans‐Michael Steffen

134 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NAFLD and cardiovascular diseases: a clinical review

2020 397 citations Philipp Kasper, Anna Martin et al. Clinical Research in Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans‐Michael Steffen Germany	29	1.1k	869	521	447	437	139	3.2k
Kaori Suzuki Japan	31	701 0.6×	1.9k 2.1×	241 0.5×	608 1.4×	354 0.8×	102	4.0k
Takashi Goto Japan	22	967 0.9×	1.4k 1.6×	533 1.0×	218 0.5×	619 1.4×	92	3.0k
Akihiro Sekine Japan	31	685 0.6×	1.5k 1.8×	320 0.6×	143 0.3×	325 0.7×	103	4.4k
Xuchen Zhang United States	35	1.1k 1.0×	2.0k 2.3×	331 0.6×	449 1.0×	410 0.9×	191	4.8k
Yuki Kimura Japan	25	479 0.4×	1.1k 1.2×	199 0.4×	215 0.5×	361 0.8×	163	3.3k
Willscott E. Naugler United States	24	1.4k 1.3×	1.6k 1.9×	215 0.4×	1.0k 2.3×	441 1.0×	42	4.6k
G. Perret France	28	698 0.6×	1.3k 1.5×	479 0.9×	172 0.4×	188 0.4×	122	3.9k
Keiji Kuba Japan	29	408 0.4×	1.3k 1.4×	360 0.7×	358 0.8×	225 0.5×	59	5.2k
Hisahiko Sekihara Japan	39	886 0.8×	2.2k 2.5×	1.2k 2.4×	734 1.6×	556 1.3×	133	5.3k
J Giboudeau France	28	735 0.7×	468 0.5×	245 0.5×	610 1.4×	409 0.9×	104	2.5k

Countries citing papers authored by Hans‐Michael Steffen

Since Specialization

Citations

This map shows the geographic impact of Hans‐Michael Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Michael Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Michael Steffen more than expected).

Fields of papers citing papers by Hans‐Michael Steffen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Michael Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Michael Steffen. The network helps show where Hans‐Michael Steffen may publish in the future.

Co-authorship network of co-authors of Hans‐Michael Steffen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Michael Steffen. A scholar is included among the top collaborators of Hans‐Michael Steffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Michael Steffen. Hans‐Michael Steffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Anna, Sonja Lang, Seung‐Hun Chon, et al.. (2025). Nocturnal hypertension represents an uncontrolled burden in patients with metabolic dysfunction-associated steatotic liver disease. Journal of Hypertension. 43(5). 814–821.

Kasper, Philipp, Sonja Lang, Hans‐Michael Steffen, & Münevver Demir. (2023). Management of alcoholic hepatitis: A clinical perspective. Liver International. 43(10). 2078–2095. 19 indexed citations

Steffen, Hans‐Michael, Florian Neuhann, Philipp Kasper, et al.. (2023). Blood pressure changes during tenofovir-based antiretroviral therapy among people living with HIV in Lilongwe, Malawi: results from the prospective LighTen Cohort Study. Clinical Research in Cardiology. 112(11). 1650–1663. 5 indexed citations

Reuken, Philipp A., Matthias Reichert, Fabian Finkelmeier, et al.. (2023). Evaluation of Ultrasound-based Surveillance for Hepatocellular Carcinoma in Patients at Risk: Results From a German Multicenter Retrospective Cohort Study. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations

Kasper, Philipp, Christina Vohlen, Inga Bae‐Gartz, et al.. (2022). Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling in Male Offspring of Obese Mice. International Journal of Molecular Sciences. 23(10). 5609–5609. 8 indexed citations

Demir, Münevver, Sonja Lang, Phillipp Hartmann, et al.. (2021). The fecal mycobiome in non-alcoholic fatty liver disease. Journal of Hepatology. 76(4). 788–799. 131 indexed citations

Lang, Sonja, Anna Martin, Xinlian Zhang, et al.. (2021). Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease. Liver International. 41(7). 1576–1591. 22 indexed citations

Schulte, S, Fabian Kütting, Jessica Mertens, et al.. (2019). Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine. BMC Gastroenterology. 19(1). 36–36. 15 indexed citations

Demir, Münevver, Sonja Lang, Christoph Schramm, et al.. (2016). Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Medicine. 95(38). e4602–e4602. 7 indexed citations

10.

Steffen, Hans‐Michael, et al.. (2015). Peripheral Hemodynamics, Blood Viscosity, and the Renin-Angiotensin System in Hemodialysis Patients under Therapy with Recombinant Human Erythropoietin. Contributions to nephrology. 76. 292–298. 2 indexed citations

11.

Demir, Münevver, Fabian Kütting, Andrea Bowe, et al.. (2015). Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center. Infection. 43(2). 153–162. 3 indexed citations

12.

Brault, C., Pierre Lévy, Maud Michelet, et al.. (2014). Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity. Gut. 65(1). 144–154. 45 indexed citations

13.

Elfimova, N, Elisabeth Sievers, M Kwiecinski, et al.. (2013). Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(5). 1190–1198. 29 indexed citations

14.

Markus, A., Nicolai Rosager Weber, Hans‐Michael Steffen, et al.. (2007). Pulmonale Nokardiose mit Trimethoprim/Sulfamethoxazol resistenter Nocardia paucivorans bei einem Patienten ohne Hinweise auf Immunsuppression. Pneumologie. 61(1). 46–51. 3 indexed citations

15.

Bethke, T.D., et al.. (2004). Long-term Safety of Roflumilast in the Treatment of Chronic Obstructive Pulmonary Disease. CHEST Journal. 126(4). 805S–805S. 1 indexed citations

16.

Steffen, Hans‐Michael. (1999). Amlodipine - a third generation dihydropyridine calcium antagonist. Journal of clinical and basic cardiology. 2(1). 45–52. 11 indexed citations

17.

Steffen, Hans‐Michael, Gerd U. Auffarth, & G. Kolling. (1998). Posterior fixation suture and convergence excess esotropia. Strabismus. 6(3). 117–126. 12 indexed citations

18.

Ukena, D., Ulf Harnest, Raimundas Sakalauskas, et al.. (1997). Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. European Respiratory Journal. 10(12). 2754–2760. 109 indexed citations

19.

Bormann, Richard, et al.. (1987). Microscopic findings after tissue sticking with autologous fibrin. Pathology - Research and Practice. 182(4). 498. 1 indexed citations

20.

Steffen, Hans‐Michael. (1977). [Appendicitis in childhood--an analytical study].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 71(14). 666–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact